Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza.
Employers may be loath to fund vaccination programs without understanding the economic consequences. We developed a decision analytic computational simulation model including dynamic transmission elements that estimated the cost-benefit of employer-sponsored workplace vaccination from the employer's perspective. Implementing such programs was relatively inexpensive (<$35/vaccinated employee) and, in many cases, cost saving across diverse occupational groups in all seasonal influenza scenarios. Such programs were cost-saving for a 20% serologic attack rate pandemic scenario (range: -$15 to -$995) per vaccinated employee) and a 30% serologic attack rate pandemic scenario (range: -$39 to -$1,494 per vaccinated employee) across all age and major occupational groups.
Lee
Bruce Y
BY
Applied Modeling, Public Health Computational and Operations Research, University of Pittsburgh, Pittsburgh, PA 15213, USA. BYL1@pitt.edu
Bailey
Rachel R
RR
Wiringa
Ann E
AE
Afriyie
Abena
A
Wateska
Angela R
AR
Smith
Kenneth J
KJ
Zimmerman
Richard K
RK
D003198:Computer Simulation; D003362:Cost-Benefit Analysis; D003657:Decision Making; D004196:Disease Outbreaks / Q000517:prevention & control*; D006801:Humans; D007252:Influenza Vaccines / Q000191:economics*; D007251:Influenza, Human / Q000453:epidemiology / Q000517:prevention & control*; D018803:Models, Economic; D014611:Vaccination / Q000191:economics*; D017132:Workplace
D007252:Influenza Vaccines